|
ATP2C1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.02210000000469E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.036900E-03 |
| Normal-vs-Stage2 |
3.042300E-03 |
| Normal-vs-Stage3 |
5.76579999966853E-07 |
| Normal-vs-Stage4 |
6.90130000036149E-07 |
| Stage1-vs-Stage2 |
4.369000E-01 |
| Stage1-vs-Stage3 |
7.279700E-03 |
| Stage1-vs-Stage4 |
2.197200E-03 |
| Stage2-vs-Stage3 |
2.483000E-01 |
| Stage2-vs-Stage4 |
1.160760E-01 |
| Stage3-vs-Stage4 |
4.832800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.96813999999712E-05 |
| Normal-vs-AfricanAmerican |
9.127800E-02 |
| Normal-vs-Asian |
7.067700E-02 |
| Caucasian-vs-AfricanAmerican |
2.575800E-01 |
| Caucasian-vs-Asian |
1.340040E-01 |
| AfricanAmerican-vs-Asian |
9.834000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.85910000000322E-05 |
| Normal-vs-Female |
2.811000E-04 |
| Male-vs-Female |
3.861800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.890200E-02 |
| Normal-vs-Age(41-60Yrs) |
3.61899999999915E-05 |
| Normal-vs-Age(61-80Yrs) |
1.36729999988816E-07 |
| Normal-vs-Age(81-100Yrs) |
1.497600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.577950E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.632100E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.410800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.666380E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.281600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.871600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.553500E-04 |
| Classical-VS-Follicular |
2.300700E-03 |
| Classical-VS-Other |
7.036000E-01 |
| Classical-VS-Normal |
5.340900E-03 |
| Tall-VS-Follicular |
3.751800E-01 |
| Tall-VS-Other |
2.237800E-01 |
| Tall-VS-Normal |
2.53530000005053E-06 |
| Follicular-VS-Other |
5.156400E-01 |
| Follicular-VS-Normal |
1.65860000000961E-06 |
| Other-VS-Normal |
1.233190E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.74077999999245E-05 |
| Normal-vs-N1 |
1.58185999999949E-05 |
| N0-vs-N1 |
2.613200E-01 |
|
|
